Syra Health Corp

SYRA OTC SEC CIK 1922335
Follow Syra Health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.6M +51.5% vs same quarter last year
Net income $344.6K +252.5% vs same quarter last year
EPS, diluted $0.02 +200% vs same quarter last year
Operating cash flow $331.8K +235.8% vs same quarter last year
Revenue by quarter
$2M
$1.9M
$1.9M
$1.7M
$1.7M
$2.3M
$2.4M
$2.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$5M$0$5M$10MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$7.2M−$896.3K
FY24$8M−$3.8M
FY23$5.5M−$2.9M
FY22$5.6M−$2.1M
FY21--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−75%−50%−25%0%25%50%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2534.4%−12.5%−12.4%
FY2420.7%−47.2%−47.1%
FY2325.6%−52.4%−53.3%
FY2218.9%−37.2%−37.7%
FY21---
Free cash flowOperating cash flow minus capital expenditure
−$3M−$2M−$1M$0FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$447.9K
FY24−$2.9M
FY23−$2.8M
FY22−$2.4M
FY21-
Net margin vs the sectorMedian of Industrials companies filing with the SEC
  • Syra Health
  • Industrials median
−60%−40%−20%0%20%FY21FY22FY23FY24FY25
Show the numbers
YearSyra HealthIndustrials median
FY25−12.4%2.5%
FY24−47.1%3.3%
FY23−53.3%3.7%
FY22−37.7%3.8%
FY21-3.7%